Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled add-on trial of R1678 in schizophrenia outpatients
jRCT2080220620Phase 2
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bitopertin in schizophrenia (4 arms), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080220620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220620.